We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

UK shares: why Purplebricks, Chemring and K3 Capital are rising today

Three popular UK shares saw gains of 10% or more in early trade. Roland Head looks at the latest news from Chemring, K3 Capital and Purplebricks.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

This morning has brought strong results from Purplebricks Group (LSE: PURP), Chemring Group (LSE: CHG) and K3 Capital (LSE: K3C). These UK shares are popular with private investors. All three saw gains of 10% or more in early trading.

Purplebricks returns to profit

Purplebricks’ share price is up by 13% as I write, after the online estate agency reported a return to profit during the first half of the year. Management said the firm has seen “a strong market recovery”.

Should you buy Chemring Group Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Although revenue fell 6% to £44.2m, Purplebricks reported a pre-tax profit for the half year of £4.3m. This compares to a loss of £2.3m for the same period last year. Adjusted profits for the full year are now expected to be ahead of broker forecasts.

Today’s results highlight some encouraging trends. Fee income rose by 6% to £49.1m. This was helped by an increase in the number of new instructions, which rose by 8% to 35,387. Average revenue per instruction rose by 3% to £1,392. This suggests that Purplebricks is not having to discount its services to win new business — good news for profits.

Purplebricks says that it now has 4.8% of the UK market and ended the half-year period with £75.8m of cash on hand. Investors are likely to view today’s results as a sign that this UK share’s growth story is back on track.

Profits flare at Chemring

Chemring’s share price is up by 12% to over 300p this morning, after the defence group reported full-year profits that were ahead of broker forecasts.

Sales rose by 20% to £402.5m during the year to 31 October. This lifted the group’s underlying pre-tax profit by 31% to £51.7m. Adjusted earnings per share climbed 35% to 15.1p, ahead of broker forecasts of 14p.

The company says that its businesses have remained open and fully operational this year, despite the impact of Covid-19. There’s been “good progress” with new orders for countermeasures, such as flares that are used as missile decoys. Recent contracts include a $107m order in Australia to support the F-35 Lightning combat aircraft.

Management said expectations for 2021 are unchanged. Chemring’s current order book covers 78% of 2021 forecast revenue, suggesting a fairly stable outlook for the year.

This UK share is rising fast

The share price of business broker K3 Capital is up by almost 10% as I write, after the firm said that trading was ahead of expectations during the six months to 30 November. As a result, management expects to report half-year revenue of £18m. That’s more than double last year’s half-year revenue of £8m.

K3 Capital’s share price has risen by 40% over the last six months. This AIM-listed company appears to be in a strong growth phase, which management said has been helped by the recent acquisition of insolvency specialist Quantuma. It added that the company has entered the second half of the year with “strong momentum”.

CEO John Rigby owns 11% of this £140m business, giving him plenty of skin in the game. Mr Rigby said that he’s continuing to look for new acquisition opportunities and is confident of further progress.

According to broker forecasts, K3 Capital’s earnings will be largely unchanged this year, before rising by 40% to 16p in the 2021/22 financial year. At current levels, that leaves this growth stock trading on 14 times 2021/22 forecast earnings.

Roland Head owns shares of K3 Capital. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A row of satellite radars at night
Investing Articles

This ex-penny stock has crushed Rolls-Royce shares over 5 years! Is there more to come?

With all eyes on Rolls-Royce shares, this growth share with a connection to SpaceX might have gone unnoticed by a…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

With a 6.4% yield and P/E of 10 is this FTSE dividend stock a hidden passive income gem?

Building a portfolio of solid UK dividend stocks isn't hard. Paul Summers takes a closer look at one high-yielding candidate…

Read more »

Black woman using smartphone at home, watching stock charts.
Growth Shares

At 112p, where next for the Lloyds share price? 168p or 56p?

Jon Smith mulls over the direction going forward for the Lloyds share price, and explains why two very different scenarios…

Read more »

Investing Articles

This dividend stock has a 7.3% yield, and Stocks and Shares ISA investors are buying!

Looking to move from a Cash ISA to a Stocks and Shares ISA to target passive income? Alan Oscroft has…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

Could Rolls-Royce shares lock in another 34% gain before Christmas?

Mark Hartley takes a look at some of the more optimistic price targets for Rolls-Royce, and considers a best-case scenario.…

Read more »

This way, That way, The other way - pointing in different directions
Investing Articles

Investec vs Aberdeen: which is the better income stock to buy?

Aiming to boost the average yield of his income portfolio, Mark Hartley's looking for new income stocks to buy on…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Down 41% since January, this quality S&P 500 stock is stinking out my ISA

The tide's turned against this S&P 500 robotics stock. Is it time to dump it? Or is there a no-brainer…

Read more »

GSK scientist holding lab syringe
Investing Articles

By mid-2027, analysts expect £6,000 in GSK shares to be worth…

GSK shares are currently trading almost 20% below their 2026 highs. Is there potential for a rebound over the next…

Read more »